Search research articles
Contact Us
Filters
Showing results (271-280 of 342) with videos related to
Page
of 35
Sort By:
Cytogenetic and Genome Research
|
August 12, 2004
High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue
M Zielenska, P Marrano, P Thorner, et al.
Molecular Carcinogenesis
|
July 15, 2005
DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?
Leda I C V Esteves, Afonso C Javaroni, Inês N Nishimoto, et al.
Expert Review of Proteomics
|
March 15, 2016
Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery
Muhammad Nawaz, Farah Fatima, Irina Nazarenko, et al.
British Journal of Cancer
|
April 1, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
M Koti, A Siu, I Clément, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2005
Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients
Nádia Aparecida Bérgamo, Luciana Caricati da Silva Veiga, Patricia Pintor dos Reis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 29, 2012
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade
Maisa Yoshimoto, Keyue Ding, Joan M Sweet, et al.
Molecular Cytogenetics
|
May 4, 2024
Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
William Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
The Journal of Pathology
|
March 8, 2011
PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome
Yunru Li, Jie Su, Xiao DingZhang, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
April 7, 2007
Expression of major vault protein gene in osteosarcoma patients
Cristiane Arruda Dalla-Torre, Silvia Regina Caminada de Toledo, Maisa Yoshimoto, et al.
International Journal of Cancer
|
January 13, 2005
Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma
Kathy Y-Y Chan, Nathalie Wong, Paul B-S Lai, et al.
Page
of 35
Search research articles
Search
Showing results (271-280 of 342) with videos related to
Sort By:
Page
of 35
Cytogenetic and Genome Research
|
August 12, 2004
High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue
M Zielenska, P Marrano, P Thorner, et al.
Molecular Carcinogenesis
|
July 15, 2005
DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?
Leda I C V Esteves, Afonso C Javaroni, Inês N Nishimoto, et al.
Expert Review of Proteomics
|
March 15, 2016
Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery
Muhammad Nawaz, Farah Fatima, Irina Nazarenko, et al.
British Journal of Cancer
|
April 1, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
M Koti, A Siu, I Clément, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2005
Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients
Nádia Aparecida Bérgamo, Luciana Caricati da Silva Veiga, Patricia Pintor dos Reis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 29, 2012
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade
Maisa Yoshimoto, Keyue Ding, Joan M Sweet, et al.
Molecular Cytogenetics
|
May 4, 2024
Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer
William Lautert-Dutra, Camila M Melo, Luiz P Chaves, et al.
The Journal of Pathology
|
March 8, 2011
PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome
Yunru Li, Jie Su, Xiao DingZhang, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
April 7, 2007
Expression of major vault protein gene in osteosarcoma patients
Cristiane Arruda Dalla-Torre, Silvia Regina Caminada de Toledo, Maisa Yoshimoto, et al.
International Journal of Cancer
|
January 13, 2005
Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma
Kathy Y-Y Chan, Nathalie Wong, Paul B-S Lai, et al.
Page
of 35